Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Castillo-Aguilar (Mexico, Mexico), A. Orea-Tejeda (Mexico, Mexico), D. González-Islas (Mexico, Mexico), C. Chávez Méndez (Mexico, Mexico), G. Dávila-Said (Mexico, Mexico), C. Olivo-Villalobos (Mexico, Mexico), M. Mejía-Ávila (Mexico, Mexico), I. Buendía-Roldán (Mexico, Mexico), E. Navarro-Briseño (Mexico, Mexico), V. Peláez-Herández (Mexico, Mexico), K. Balderas-Muñoz (Mexico, Mexico), M. Rivera-Rodriguez (Mexico, Mexico), L. Hernández-Urquieta (Mexico, Mexico). Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis. 4119

Member's Comments

No comment yet.

Related content which might interest you: Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Association between percentage of  fat mass  and endothelial function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function Source: Eur Respir J 2016; 48: 843-851 Year: 2016 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013